In 2020, we commercialized the Quadrant COVID-19 Saliva Test, currently the most sensitive saliva test on the market as measured by performance on the FDA SARS-CoV-2 test reference panel. When the need for more access to PCR testing arose during the height of the pandemic, Quadrant worked with state and county officials to create over 40 pop-up sites throughout NY State and provided results for over four million New Yorkers.
In addition, our Quadrant COVID-19 Saliva Antibody Test recently received approval as a Laboratory Developed Test (LDT) from the NY State Department of Health and will launch this fall.
